<DOC>
	<DOC>NCT00413751</DOC>
	<brief_summary>The objective of this study is to evaluate the effect of brimonidine tartrate ophthalmic solution 0.15% (Alphagan P) on pupil diameter under different luminance conditions.</brief_summary>
	<brief_title>Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Adult active duty personnel between 18 and 50 years of age with best corrected visual acuity of 20/20 or better. Patients not meeting above stated age criteria Females that are pregnant or lactating (non pregnant females of childbearing potential will have pregnancy test prior to participating in study) History of serious ocular, neurological, cardiovascular disease History of severe systemic disease History of arrhythmias or high blood pressure Patients currently taking any type of ocular or systemic medications except multivitamins. Patients with abnormal pupil shape, Addie's pupil, anisocoria, or abnormal pupil defect.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>Large pupils rendering night vision difficulties such as haloes, glare, and monocular diplopia</keyword>
</DOC>